Ji Xing Pharmaceuticals
Manufacturing · 201-500 Employees
View Company Info for Free
Overview
Website
www.jixingbio.comRevenue
$18.4 MillionIndustry
About Ji Xing Pharmaceuticals
CORXEL is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with cardiometabolic conditions worldwide. The company aims to address the urgent unmet needs in the prevention and treatment of cardiovascular and metabolic diseases through its strong pipeline of investigational drugs, including JX09 and JX10. With a global team based in the United States and China, CORXEL leverages its expertise to conduct clinical studies efficiently and effectively. The long-term goal of CORXEL is to lead the treatment of cardiometabolic diseases with breakthrough therapies that can significantly improve patient outcomes.Explore more
SIC Code 28,283NAICS Code 32,325Show more
Ji Xing Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Ji Xing Pharmaceuticals Tech Stack
A closer look at the technologies used by Ji Xing Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ji Xing Pharmaceuticals
Sign Up For FreeTo access detailed company insights
CORXEL is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with cardiometabolic conditions worldwide. The company aims to address the urgent unmet needs in the prevention and treatment of cardiovascular and metabolic diseases through its strong pipeline of investigational drugs, including JX09 and J... Read More
